Related Experiment Video

Updated: Jan 4, 2026

Preterm EEG: A Multimodal Neurophysiological Protocol
19:32

Preterm EEG: A Multimodal Neurophysiological Protocol

Published on: February 18, 2012

28.9K

Caffeine Therapy in Preterm Infants: The Dose (and Timing) Make the Medicine

Sara E Rostas, Christopher McPherson

    Neonatal Network : NN
    |November 13, 2019
    PubMed

    Insights

    Caffeine is a common NICU medication for preterm infants, offering pulmonary and neurodevelopmental benefits. However, optimal dosing, timing, and safety limits require further research to guide clinical practice effectively.

    Area of Science:

    • Neonatalogy
    • Pharmacology
    • Developmental Pediatrics

    Background:

    • Caffeine is frequently administered in Neonatal Intensive Care Units (NICUs).
    • Established benefits include pulmonary and neurodevelopmental improvements in preterm infants.
    • Current evidence supports standard caffeine doses for apnea of prematurity and extubation support.

    Purpose of the Study:

    • To review the current evidence on caffeine therapy in preterm infants.
    • To explore the efficacy and safety boundaries of escalating caffeine doses.
    • To examine optimal timing for caffeine initiation and discontinuation.

    Main Methods:

    • Literature review of studies on caffeine therapy in preterm infants.
    • Analysis of data on dosing, timing, efficacy, and toxicity.
    • Evaluation of conflicting evidence regarding caffeine use.

    Main Results:

    • Standard caffeine doses are well-supported for specific indications.
    • Higher doses may offer benefits but carry risks of toxicity.
    • Data on optimal initiation and discontinuation times are conflicting.

    Conclusions:

    • Further research is needed to define precise dosing and timing strategies.
    • Clinical practice should adhere to current evidence-based guidelines for safe and effective caffeine use.
    • The boundaries of caffeine efficacy and safety in preterm infants warrant continued investigation.

    Keywords:
    apnea of prematuritybronchopulmonary dysplasiacaffeinemethylxanthinepharmacologypremature infant

    More Related Videos

    Clinical Practice Protocol of Creative Music Therapy for Preterm Infants and Their Parents in the Neonatal Intensive Care Unit11:50

    Clinical Practice Protocol of Creative Music Therapy for Preterm Infants and Their Parents in the Neonatal Intensive Care Unit

    Published on: January 7, 2020

    27.4K
    Application of an Amplitude-integrated EEG Monitor Cerebral Function Monitor to Neonates05:58

    Application of an Amplitude-integrated EEG Monitor Cerebral Function Monitor to Neonates

    Published on: September 6, 2017

    40.3K

    Related Concept Videos

    Drug Dosing: Infants and Children01:29

    Drug Dosing: Infants and Children

    Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
    218
    Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

    Pharmacokinetics in Pediatric Patients: Drug Excretion

    In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
    177
    Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

    Pharmacokinetics in Pediatric Patients: Drug Metabolism

    In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
    156
    Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

    Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

    Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
    206
    Factors Affecting Drug Response: Overview01:21

    Factors Affecting Drug Response: Overview

    When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
    2.8K
    Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response01:15

    Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response

    Circadian rhythms are cyclic changes that are crucial in plasma drug concentrations. Various standard circadian parameters, including core body temperature, heart rate, and other cardiovascular factors, directly impact disease states and the therapeutic response to drug therapy.
    The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
    317